2024 Q4 Form 10-K Financial Statement

#000095017024129020 Filed on November 20, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2024
Revenue $33.23M $126.1M
YoY Change 18.8% -4.91%
Cost Of Revenue $8.674M $33.03M
YoY Change 23.23% 32.29%
Gross Profit $24.55M $93.05M
YoY Change 17.3% -13.54%
Gross Profit Margin 73.89% 73.81%
Selling, General & Admin $14.58M $56.84M
YoY Change 13.84% 9.54%
% of Gross Profit 59.38% 61.08%
Research & Development $9.702M $38.36M
YoY Change 0.06% -17.67%
% of Gross Profit 39.51% 41.22%
Depreciation & Amortization $2.139M $8.694M
YoY Change -0.6% 2.02%
% of Gross Profit 8.71% 9.34%
Operating Expenses $25.17M $98.70M
YoY Change 7.63% 0.22%
Operating Profit -$613.0K -$5.645M
YoY Change -74.98% -209.61%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$524.0K -$1.861M
YoY Change -30.12%
Pretax Income -$1.137M -$7.506M
YoY Change -59.23% -401.81%
Income Tax $2.312M $4.036M
% Of Pretax Income
Net Earnings -$3.449M -$11.54M
YoY Change -151.52% 651.43%
Net Earnings / Revenue -10.38% -9.15%
Basic Earnings Per Share -$0.82
Diluted Earnings Per Share -$0.24 -$0.82
COMMON SHARES
Basic Shares Outstanding 14.33M 14.27M 14.15M
Diluted Shares Outstanding 14.15M

Balance Sheet

Concept 2024 Q4 2024 Q3 2024
SHORT-TERM ASSETS
Cash & Short-Term Investments $40.11M $40.11M
YoY Change -11.55% -11.55%
Cash & Equivalents $36.12M $36.12M
Short-Term Investments $3.997M $3.997M
Other Short-Term Assets $2.860M $2.860M
YoY Change -52.66% -52.66%
Inventory $15.17M $15.17M
Prepaid Expenses $2.752M
Receivables $23.16M $23.16M
Other Receivables $0.00 $0.00
Total Short-Term Assets $81.30M $81.30M
YoY Change -6.21% -6.21%
LONG-TERM ASSETS
Property, Plant & Equipment $24.96M $24.96M
YoY Change -4.11% -13.98%
Goodwill $44.64M
YoY Change 3.94%
Intangibles $23.57M
YoY Change -10.06%
Long-Term Investments
YoY Change
Other Assets $4.093M $4.093M
YoY Change 5.93% 366.7%
Total Long-Term Assets $97.26M $97.26M
YoY Change -1.8% -1.8%
TOTAL ASSETS
Total Short-Term Assets $81.30M $81.30M
Total Long-Term Assets $97.26M $97.26M
Total Assets $178.6M $178.6M
YoY Change -3.86% -3.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.786M
YoY Change -6.92%
Accrued Expenses $3.795M
YoY Change -41.11%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $20.54M $20.54M
YoY Change -14.24% -14.24%
LONG-TERM LIABILITIES
Long-Term Debt $29.55M $29.55M
YoY Change 0.51% 0.51%
Other Long-Term Liabilities $9.568M $9.568M
YoY Change 18.71% -8.53%
Total Long-Term Liabilities $39.12M $39.12M
YoY Change 385.38% -1.86%
TOTAL LIABILITIES
Total Short-Term Liabilities $20.54M $20.54M
Total Long-Term Liabilities $39.12M $39.12M
Total Liabilities $59.67M $59.67M
YoY Change -9.36% -9.36%
SHAREHOLDERS EQUITY
Retained Earnings $75.71M
YoY Change -13.23%
Common Stock $45.31M
YoY Change 21.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $118.9M $118.9M
YoY Change
Total Liabilities & Shareholders Equity $178.6M $178.6M
YoY Change -3.86% -3.86%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2024
OPERATING ACTIVITIES
Net Income -$3.449M -$11.54M
YoY Change -151.52% 651.43%
Depreciation, Depletion And Amortization $2.139M $8.694M
YoY Change -0.6% 2.02%
Cash From Operating Activities $3.658M $248.0K
YoY Change 191.71% -97.64%
INVESTING ACTIVITIES
Capital Expenditures $542.0K $3.492M
YoY Change -27.54% 19.67%
Acquisitions
YoY Change
Other Investing Activities $10.00M $555.0K
YoY Change -356.15% -114.22%
Cash From Investing Activities $9.458M -$2.937M
YoY Change -303.31% -56.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.216M
YoY Change -2.88%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.562M -2.950M
YoY Change -475.48% -116.03%
NET CHANGE
Cash From Operating Activities 3.658M 248.0K
Cash From Investing Activities 9.458M -2.937M
Cash From Financing Activities -1.562M -2.950M
Net Change In Cash 11.55M -5.639M
YoY Change -487.46% -125.15%
FREE CASH FLOW
Cash From Operating Activities $3.658M $248.0K
Capital Expenditures $542.0K $3.492M
Free Cash Flow $3.116M -$3.244M
YoY Change 515.81% -142.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0000924717
CY2024 dei Amendment Flag
AmendmentFlag
false
CY2024 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2024 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2024#ProductMember
CY2023 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2024#ProductMember
CY2022 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2024#ProductMember
CY2023Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent
CY2024Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent
CY2024Q3 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2023Q3 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2023 us-gaap Derivative Instrument Gain Loss Reclassified From Aoci Into Income Effective Portion Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
CY2024 us-gaap Derivative Instrument Gain Loss Reclassified From Aoci Into Income Effective Portion Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2024 dei Document Type
DocumentType
10-K
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024 dei Document Transition Report
DocumentTransitionReport
false
CY2024 dei Entity File Number
EntityFileNumber
0-23837
CY2024 dei Entity Registrant Name
EntityRegistrantName
Surmodics, Inc
CY2024 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MN
CY2024 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-1356149
CY2024 dei Entity Address Address Line1
EntityAddressAddressLine1
9924 West 74th Street
CY2024 dei Entity Address City Or Town
EntityAddressCityOrTown
Eden Prairie
CY2024 dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
CY2024 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55344
CY2024 dei City Area Code
CityAreaCode
952
CY2024 dei Local Phone Number
LocalPhoneNumber
500-7000
CY2024 dei Security12b Title
Security12bTitle
Common Stock, $0.05 par value
CY2024 dei Trading Symbol
TradingSymbol
SRDX
CY2024 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2024 dei Entity Small Business
EntitySmallBusiness
false
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Public Float
EntityPublicFloat
401000000
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14326000
CY2024 cyd Cybersecurity Risk Third Party Oversight And Identification Processes Flag
CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag
true
CY2024 cyd Cybersecurity Risk Management Third Party Engaged Flag
CybersecurityRiskManagementThirdPartyEngagedFlag
true
CY2024 cyd Cybersecurity Risk Materially Affected Or Reasonably Likely To Materially Affect Registrant Flag
CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag
false
CY2024 cyd Cybersecurity Risk Management Positions Or Committees Responsible Flag
CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag
true
CY2024 cyd Cybersecurity Risk Management Positions Or Committees Responsible Report To Board Flag
CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag
true
CY2024 dei Auditor Firm
AuditorFirmId
34
CY2024 dei Auditor Name
AuditorName
Deloitte & Touche LLP
CY2024 dei Auditor Location
AuditorLocation
Minneapolis, Minnesota
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36115000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
41419000
CY2024Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
3997000
CY2023Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
3933000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
144000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
80000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13292000
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10850000
CY2024Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
9872000
CY2023Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
7796000
CY2024Q3 us-gaap Inventory Net
InventoryNet
15168000
CY2023Q3 us-gaap Inventory Net
InventoryNet
14839000
CY2023Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
491000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2860000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7363000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
81304000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
86691000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24956000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26026000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23569000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
26206000
CY2024Q3 us-gaap Goodwill
Goodwill
44640000
CY2023Q3 us-gaap Goodwill
Goodwill
42946000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4093000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3864000
CY2024Q3 us-gaap Assets
Assets
178562000
CY2023Q3 us-gaap Assets
Assets
185733000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2786000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2993000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11099000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10139000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3795000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6444000
CY2024Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1619000
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4378000
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1244000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
20543000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
23954000
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
29554000
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
29405000
CY2023Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2400000
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1785000
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2004000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7783000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8060000
CY2024Q3 us-gaap Liabilities
Liabilities
59665000
CY2023Q3 us-gaap Liabilities
Liabilities
65823000
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.05
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.05
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
450000
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
450000
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14325000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14325000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14155000
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14155000
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
716000
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
708000
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
44594000
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
36706000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2126000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4759000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
75713000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
87255000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
118897000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
119910000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
178562000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
185733000
CY2024 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
126078000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
132584000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
99951000
CY2024 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
33026000
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
24965000
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
20342000
CY2024 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
38360000
CY2023 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
46595000
CY2022 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
50609000
CY2024 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
56836000
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
51884000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
46935000
CY2024 srdx Acquisition Related Intangible Asset Amortization
AcquisitionRelatedIntangibleAssetAmortization
3501000
CY2023 srdx Acquisition Related Intangible Asset Amortization
AcquisitionRelatedIntangibleAssetAmortization
3537000
CY2022 srdx Acquisition Related Intangible Asset Amortization
AcquisitionRelatedIntangibleAssetAmortization
4150000
CY2023 us-gaap Restructuring Charges
RestructuringCharges
1282000
CY2023 srdx Contingent Consideration Expense Gain
ContingentConsiderationExpenseGain
-829000
CY2022 srdx Contingent Consideration Expense Gain
ContingentConsiderationExpenseGain
12000
CY2024 us-gaap Costs And Expenses
CostsAndExpenses
131723000
CY2023 us-gaap Costs And Expenses
CostsAndExpenses
127434000
CY2022 us-gaap Costs And Expenses
CostsAndExpenses
122048000
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
-5645000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
5150000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-22097000
CY2024 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
3540000
CY2023 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
3489000
CY2022 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
598000
CY2024 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-243000
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-251000
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
103000
CY2024 us-gaap Investment Income Net
InvestmentIncomeNet
1922000
CY2023 us-gaap Investment Income Net
InvestmentIncomeNet
1077000
CY2022 us-gaap Investment Income Net
InvestmentIncomeNet
99000
CY2024 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1861000
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2663000
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-396000
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7506000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2487000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22493000
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4036000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4023000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4781000
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-11542000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1536000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-27274000
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.82
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.96
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.82
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.96
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14153000
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14031000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13916000
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14153000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14031000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13916000
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-11542000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1536000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-27274000
CY2024 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Before Adjustments After Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
-611000
CY2023 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Before Adjustments After Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
260000
CY2024 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Adjustments After Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
245000
CY2023 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Adjustments After Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
77000
CY2024 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
6000
CY2023 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-6000
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000
CY2024 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3483000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
4938000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-11600000
CY2024 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2633000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5115000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-11601000
CY2024 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8909000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3579000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-38875000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
140085000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-27274000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-11601000
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
832000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
414000
CY2022 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1121000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7057000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
108392000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1536000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5115000
CY2023 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
850000
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
402000
CY2023 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
918000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7605000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
119910000
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-11542000
CY2024 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2633000
CY2024 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
860000
CY2024 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
356000
CY2024 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1537000
CY2024 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8217000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
118897000
CY2024 us-gaap Profit Loss
ProfitLoss
-11542000
CY2023 us-gaap Profit Loss
ProfitLoss
-1536000
CY2022 us-gaap Profit Loss
ProfitLoss
-27274000
CY2024 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8694000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8522000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9142000
CY2024 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8217000
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7605000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7057000
CY2024 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
804000
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
652000
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
529000
CY2024 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
303000
CY2023 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
365000
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
46000
CY2024 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
64000
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
37000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
5000
CY2023 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-829000
CY2022 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
12000
CY2024 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-320000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-181000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
5268000
CY2024 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
613000
CY2023 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-115000
CY2022 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-268000
CY2024 srdx Increase Decrease In Accounts Receivable And Contract With Customer Asset
IncreaseDecreaseInAccountsReceivableAndContractWithCustomerAsset
5236000
CY2023 srdx Increase Decrease In Accounts Receivable And Contract With Customer Asset
IncreaseDecreaseInAccountsReceivableAndContractWithCustomerAsset
977000
CY2022 srdx Increase Decrease In Accounts Receivable And Contract With Customer Asset
IncreaseDecreaseInAccountsReceivableAndContractWithCustomerAsset
1522000
CY2024 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
328000
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3020000
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5060000
CY2024 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4902000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
665000
CY2024 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-232000
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-183000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1608000
CY2024 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-885000
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1024000
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
132000
CY2024 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1579000
CY2023 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
3438000
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1069000
CY2024 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-5159000
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2470000
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-5700000
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
248000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10514000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17223000
CY2024 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3492000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2918000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3370000
CY2024 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
25445000
CY2023 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
3904000
CY2024 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
26000000
CY2022 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
9600000
CY2024 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2937000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6822000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
6230000
CY2023 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
10000000
CY2023 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
29664000
CY2023 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
614000
CY2024 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1216000
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1252000
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1246000
CY2024 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1537000
CY2023 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
918000
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1121000
CY2024 srdx Payments For Acquisition Of In Process Research And Development
PaymentsForAcquisitionOfInProcessResearchAndDevelopment
931000
CY2023 srdx Payments For Acquisition Of In Process Research And Development
PaymentsForAcquisitionOfInProcessResearchAndDevelopment
978000
CY2022 srdx Payments For Acquisition Of In Process Research And Development
PaymentsForAcquisitionOfInProcessResearchAndDevelopment
500000
CY2024 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1698000
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2950000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18406000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-375000
CY2024 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
335000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
323000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-787000
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5304000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
22421000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12155000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
41419000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
18998000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
31153000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
36115000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
41419000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
18998000
CY2024 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2568000
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2851000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
416000
CY2024 us-gaap Interest Paid Net
InterestPaidNet
3045000
CY2023 us-gaap Interest Paid Net
InterestPaidNet
2919000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
415000
CY2024 srdx Non Cash Transaction Acquisition Of Property And Equipment Funded Through Accounts Payable And Accrued Liabilities
NonCashTransactionAcquisitionOfPropertyAndEquipmentFundedThroughAccountsPayableAndAccruedLiabilities
94000
CY2023 srdx Non Cash Transaction Acquisition Of Property And Equipment Funded Through Accounts Payable And Accrued Liabilities
NonCashTransactionAcquisitionOfPropertyAndEquipmentFundedThroughAccountsPayableAndAccruedLiabilities
116000
CY2022 srdx Non Cash Transaction Acquisition Of Property And Equipment Funded Through Accounts Payable And Accrued Liabilities
NonCashTransactionAcquisitionOfPropertyAndEquipmentFundedThroughAccountsPayableAndAccruedLiabilities
70000
CY2024 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
845000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1725000
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:12pt;font-family:Calibri;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Calibri;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Ultimate results could differ from those estimates.</span></p>
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4000000
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3900000
CY2024Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
3997000
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3997000
CY2023Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
3936000
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3000
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3933000
CY2023Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
0
CY2024Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
0
CY2022 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0
CY2024 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0
CY2023 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0
CY2024Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2600000
CY2023Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1800000
CY2024Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
8505000
CY2023Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
8063000
CY2024Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2476000
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2607000
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4187000
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4169000
CY2024Q3 us-gaap Inventory Net
InventoryNet
15168000
CY2023Q3 us-gaap Inventory Net
InventoryNet
14839000
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2752000
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2600000
CY2024Q3 srdx Irish Research And Development Credits Receivable
IrishResearchAndDevelopmentCreditsReceivable
108000
CY2023Q3 srdx Irish Research And Development Credits Receivable
IrishResearchAndDevelopmentCreditsReceivable
1322000
CY2023Q3 srdx Cares Act Employee Retention Credit Receivable
CARESActEmployeeRetentionCreditReceivable
3441000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2860000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7363000
CY2024 us-gaap Depreciation
Depreciation
4900000
CY2023 us-gaap Depreciation
Depreciation
4700000
CY2022 us-gaap Depreciation
Depreciation
4700000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
61804000
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
56467000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24956000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26026000
CY2024Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
50221000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
26652000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23569000
CY2023Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
48107000
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
21901000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
26206000
CY2024 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3800000
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3800000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4400000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
3820000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2903000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2648000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2637000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2637000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
8344000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
22989000
CY2023 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
CY2024 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
CY2022 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
CY2022Q3 us-gaap Goodwill
Goodwill
40710000
CY2023 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
2236000
CY2023Q3 us-gaap Goodwill
Goodwill
42946000
CY2024 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
1694000
CY2024Q3 us-gaap Goodwill
Goodwill
44640000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2024 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2024Q3 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
689000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4093000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3864000
CY2022 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
0
CY2024 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
0
CY2023 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
0
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
563000
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
178000
CY2024Q3 srdx Accrued Clinical Study Expense Current
AccruedClinicalStudyExpenseCurrent
499000
CY2023Q3 srdx Accrued Clinical Study Expense Current
AccruedClinicalStudyExpenseCurrent
1056000
CY2024Q3 srdx Accrued Purchases Current
AccruedPurchasesCurrent
1023000
CY2023Q3 srdx Accrued Purchases Current
AccruedPurchasesCurrent
1142000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1040000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
872000
CY2023Q3 srdx Deferred Consideration Current
DeferredConsiderationCurrent
2661000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
670000
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
535000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3795000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6444000
CY2024Q3 srdx Unrecognized Tax Benefits Including Accrued Interest And Penalties
UnrecognizedTaxBenefitsIncludingAccruedInterestAndPenalties
3176000
CY2023Q3 srdx Unrecognized Tax Benefits Including Accrued Interest And Penalties
UnrecognizedTaxBenefitsIncludingAccruedInterestAndPenalties
3332000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2648000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2974000
CY2024Q3 srdx Deferred Consideration Liability Noncurrent
DeferredConsiderationLiabilityNoncurrent
1661000
CY2023Q3 srdx Deferred Consideration Liability Noncurrent
DeferredConsiderationLiabilityNoncurrent
1629000
CY2024Q3 srdx Other Noncurrent
OtherNoncurrent
298000
CY2023Q3 srdx Other Noncurrent
OtherNoncurrent
125000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7783000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8060000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1214000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1132000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1135000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
574000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4055000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
367000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
3688000
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14153000
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14031000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13916000
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14153000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14031000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13916000
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000
CY2024 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000
CY2024Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
25300000
CY2024Q3 srdx Contract With Customer Asset Performance Coating Royalties And License Fees Current
ContractWithCustomerAssetPerformanceCoatingRoyaltiesAndLicenseFeesCurrent
8534000
CY2023Q3 srdx Contract With Customer Asset Performance Coating Royalties And License Fees Current
ContractWithCustomerAssetPerformanceCoatingRoyaltiesAndLicenseFeesCurrent
7796000
CY2024Q3 srdx Contract With Customer Asset Surveil Dcb Profit Sharing Current
ContractWithCustomerAssetSurveilDcbProfitSharingCurrent
1338000
CY2024Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
9872000
CY2023Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
7796000
CY2024Q3 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
689000
CY2024Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
10561000
CY2023Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
7796000
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1600000
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
6800000
CY2024 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
5300000
CY2023 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
4600000
CY2022 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
5700000
CY2024Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
30000000
CY2023Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
30000000
CY2024Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
446000
CY2023Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
595000
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
29554000
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
29405000
CY2023Q3 srdx Accumulated Gain Loss Cash Flow Hedge
AccumulatedGainLossCashFlowHedge
183000
CY2024 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Before Adjustments And Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
-611000
CY2023 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Before Adjustments And Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
260000
CY2024 srdx Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Before Tax
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionBeforeTax
-245000
CY2023 srdx Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Before Tax
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionBeforeTax
-77000
CY2024Q3 srdx Accumulated Gain Loss Cash Flow Hedge
AccumulatedGainLossCashFlowHedge
-673000
CY2023Q3 srdx Accumulated Gain Loss Cash Flow Hedge
AccumulatedGainLossCashFlowHedge
183000
CY2024 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8217000
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7605000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7057000
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
11100000
CY2024 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y2M12D
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0410
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0376
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0149
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y9M18D
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y8M12D
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y7M6D
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.49
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.45
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.43
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
15.69
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
15.03
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
15.96
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
922000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
39.39
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
342000
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
42.10
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
45000
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
21.24
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
58000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
43.99
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1161000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
40.66
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
311000
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
34.73
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
20000
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
21.50
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
90000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
41.77
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1362000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
39.52
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
283000
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
33.39
CY2024 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
195000
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
30.56
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
26000
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
38.75
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1424000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
39.54
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
770000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
42.33
CY2024 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
3478000
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
3363000
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-510000
CY2024 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
663000
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
591000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-143000
CY2024 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
215000
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
250000
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
166000
CY2024 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
4356000
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
4204000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-487000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
5200000
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
515000
CY2024 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-320000
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-181000
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-447000
CY2024 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-320000
CY2023 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-181000
CY2022 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
5268000
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4036000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4023000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4781000
CY2024 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1576000
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
522000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-4724000
CY2024 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-449000
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-632000
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-897000
CY2024 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
257000
CY2023 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
495000
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
628000
CY2024 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
732000
CY2023 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1544000
CY2022 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1511000
CY2024 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
4983000
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
4083000
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
10978000
CY2024 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
900000
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
1003000
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
481000
CY2024 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
169000
CY2023 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-152000
CY2024 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
-130000
CY2023 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
734000
CY2022 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
-123000
CY2024 us-gaap Income Tax Reconciliation Deductions Extraterritorial Income Exclusion
IncomeTaxReconciliationDeductionsExtraterritorialIncomeExclusion
347000
CY2023 us-gaap Income Tax Reconciliation Deductions Extraterritorial Income Exclusion
IncomeTaxReconciliationDeductionsExtraterritorialIncomeExclusion
403000
CY2024 srdx Income Tax Reconciliation Contingent Consideration
IncomeTaxReconciliationContingentConsideration
9000
CY2023 srdx Income Tax Reconciliation Contingent Consideration
IncomeTaxReconciliationContingentConsideration
-164000
CY2022 srdx Income Tax Reconciliation Contingent Consideration
IncomeTaxReconciliationContingentConsideration
13000
CY2024 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
734000
CY2024 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
218000
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
81000
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-64000
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4036000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4023000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4781000
CY2024 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
300000
CY2023 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
100000
CY2022 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
200000
CY2024Q3 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
3327000
CY2023Q3 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
3802000
CY2024Q3 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
366000
CY2023Q3 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
1082000
CY2024Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
2305000
CY2023Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
2052000
CY2024Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2850000
CY2023Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2665000
CY2024Q3 us-gaap Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
1809000
CY2023Q3 us-gaap Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
1829000
CY2024Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4774000
CY2023Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4578000
CY2024Q3 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
3277000
CY2023Q3 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
2973000
CY2024Q3 srdx Deferred Tax Assets In Capitalized Research And Development Expenses
DeferredTaxAssetsInCapitalizedResearchAndDevelopmentExpenses
12757000
CY2023Q3 srdx Deferred Tax Assets In Capitalized Research And Development Expenses
DeferredTaxAssetsInCapitalizedResearchAndDevelopmentExpenses
7976000
CY2024Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
604000
CY2023Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
648000
CY2024Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
27200000
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
22005000
CY2024Q3 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1785000
CY2023Q3 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
2004000
CY2024Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
400000
CY2024Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
4400000
CY2024Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
27200000
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
22000000
CY2022Q3 srdx Deferred Tax Assets Valuation Allowance Including Non Cash Charge To Income Tax Expense
DeferredTaxAssetsValuationAllowanceIncludingNonCashChargeToIncomeTaxExpense
10200000
CY2023Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3443000
CY2022Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2793000
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2887000
CY2024 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
13000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
53000
CY2024 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
28000
CY2023 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
4000
CY2022 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
35000
CY2024 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
587000
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
836000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
519000
CY2024 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
802000
CY2023 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
182000
CY2022 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
631000
CY2024Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3213000
CY2023Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3443000
CY2022Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2793000
CY2024Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
2800000
CY2023Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
3100000
CY2023Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
500000
CY2024Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
500000
CY2023Q3 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
0
CY2024Q3 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
0
CY2024 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
1900000
CY2023 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
1900000
CY2022 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
1700000
CY2023 us-gaap Restructuring Charges
RestructuringCharges
1300000
CY2024 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2024 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
126078000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
132584000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
99951000
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
-5645000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
5150000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-22097000
CY2024 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8694000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8522000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9142000
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 srdx Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
false
CY2024Q3 srdx Non Rule10 B51 Arr Modified Flag
NonRule10B51ArrModifiedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-129020-index-headers.html Edgar Link pending
0000950170-24-129020-index.html Edgar Link pending
0000950170-24-129020.txt Edgar Link pending
0000950170-24-129020-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img187535488_0.jpg Edgar Link pending
img187535488_1.jpg Edgar Link pending
img72077658_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
srdx-20240930.htm Edgar Link pending
srdx-20240930.xsd Edgar Link pending
srdx-ex19_1.htm Edgar Link pending
srdx-ex21.htm Edgar Link pending
srdx-ex23.htm Edgar Link pending
srdx-ex31_1.htm Edgar Link pending
srdx-ex31_2.htm Edgar Link pending
srdx-ex32_1.htm Edgar Link pending
srdx-ex32_2.htm Edgar Link pending
srdx-20240930_htm.xml Edgar Link completed